1129-53-9 Usage
Uses
Used in Pharmaceutical Synthesis:
3,4-Dihydroxyphenylacetamide is used as an intermediate in the synthesis of pharmaceuticals, specifically for the development of drugs that target neurodegenerative disorders. Its unique structure and functional groups make it a valuable component in the creation of novel therapeutic agents.
Used in Antioxidant Research:
3,4-DIHYDROXYPHENYLACETAMIDE is utilized in research as a potential antioxidant, with studies investigating its ability to protect cells from oxidative stress. Its presence in biological systems may contribute to the maintenance of cellular health and the prevention of oxidative damage.
Used in Parkinson's Disease Treatment:
3,4-Dihydroxyphenylacetamide is also being explored for its potential role in the treatment of Parkinson's disease. Its pharmacological properties suggest that it may have a positive impact on the symptoms and progression of this neurodegenerative condition.
Used in Drug Development:
In the field of drug development, 3,4-Dihydroxyphenylacetamide is used as a subject of ongoing research to understand its full potential in medicine. Its multifaceted pharmacological profile makes it a promising candidate for the development of new drugs and therapies for various conditions, particularly those related to oxidative stress and neurodegeneration.
Check Digit Verification of cas no
The CAS Registry Mumber 1129-53-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,2 and 9 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1129-53:
(6*1)+(5*1)+(4*2)+(3*9)+(2*5)+(1*3)=59
59 % 10 = 9
So 1129-53-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H9NO3/c9-8(12)4-5-1-2-6(10)7(11)3-5/h1-3,10-11H,4H2,(H2,9,12)
1129-53-9Relevant academic research and scientific papers
PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS
-
, (2010/03/02)
The invention relates to a process for straightening keratin fibres, comprising: (i) a step in which a straightening composition containing at least two denaturing agents is applied to the keratin fibres, (ii) a step in which the temperature of the keratin fibres is raised, using a heating means, to a temperature of between 110 and 250° C.
Synthesis, characterization and cardioprotective activity of some novel benzotriazole and pyrazole derivatives
Gudaparthi, Vijayalakshmi,Bharathi,Panda, Jagadeesh
experimental part, p. 5323 - 5330 (2012/07/28)
A series of N-(1-(1H-benzo[d]) [1,2,3]triazol-1-yl)-2,2-dimethyl propyl)-2-(substituted phenyl) acetamide derivatives and methyl 5-((4- (2,5-disubstituted phenyl) furan-2 carboxylate derivatives are prepared from different substituted aryl carboxylic acids, phenyl acetic acid and cinnamic acid, respectively. All the synthesized compounds are investigated for cardioprotective activity by ischemia reperfusion method, while all the compounds show significant activity.
Hydroxybenzohydroxamic acids, benzamides and esters and related compounds as ribonucleotide reductase inhibitors
-
, (2008/06/13)
Di, tri and tetrahydroxybenzohydroxamic acids, amides and the corresponding di, tri and tetrahydroxy substituted phenylalkanohydroxamic acids, amides and phenyl esters, ribonucleotide reductase inhibitors.
